Business

Hearing implant pioneer Cochlear has relieved investors with a full-year result at the upper end of its revised guidance, saying adoption of its new high-tech product has been strong.

Cochlear hits earnings guidance after two downgrades

The hearing implant pioneer has relieved investors with a full-year earnings result at the upper end of its revised guidance, saying adoption of its new high-tech product has been strong.

Updated
Read more (1 min) →